Gene Therapy for Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: Improved Retroviral Vectors for Clinical Trials

Publisher： Karger

E-ISSN： 1421-9662|101|2|89-96

ISSN： 0001-5792

Source： Acta Haematologica, Vol.101, Iss.2, 1999-04, pp. : 89-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Patents and Clinical Trials on Regenerative Therapy: Gene Therapy

By  

Recent Patents on Regenerative Medicine, Vol. 1, Iss. 2, 2011-05 ,pp. : 182-194

Bentham Science Publishers

Access to resources Recommend Favorite

Safety Profile of Plasmid/Liposomes and Virus Vectors in Clinical Gene Therapy

By  

Current Drug Safety, Vol. 1, Iss. 3, 2006-08 ,pp. : 253-257

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Significance of Serum Adenosine Deaminase Activity in Patients with Mycosis Fungoides

By  

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 7, 1993-07 ,pp. : 394-399

John Wiley & Sons Inc

Access to resources Recommend Favorite

ADENOSINE DEAMINASE IN HUMAN SKIN

By  

THE JOURNAL OF DERMATOLOGY, Vol. 8, Iss. 6, 1981-12 ,pp. : 493-497

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe combined immunodeficiency (SCID) presenting with neonatal aplastic anemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 11, 2015-11 ,pp. : 2047-2049

John Wiley & Sons Inc

Access to resources Recommend Favorite